Select a community
PSP including CBD
Find out more about the PatientsLikeMe
PSP Community
Home > Community Treatment Reports > Rasagiline Treatment Report
What is Rasagiline?

Rasagiline is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is used for initial monotherapy or as adjunct to levodopa in the treatment of idiopathic Parkinson's disease.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
tremor 1 0

Mouse over the table for more information

Dosages

  1 mg daily
  1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%

See all 1 patient who’ve stopped taking Rasagiline

Duration See details about how long patients take this treatment ▼

Currently Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Stopped Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.